PHIBRO ANIMAL HEALTH CORP
PAHCUS売上高
$1.3B
百万USD
営業利益
$110M
百万USD
純利益
$48M
百万USD
ROE
16.9%
最新FY
EPS
$1.19
USD / 株
配当
$0.48
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $12M | $0.30 |
| FY2021 | Q2 | - | $13M | $0.32 |
| FY2021 | Q3 | - | $12M | $0.30 |
| FY2021 | FY | - | $54M | $1.34 |
| FY2022 | Q1 | - | $7M | $0.16 |
| FY2022 | Q2 | - | $17M | $0.43 |
| FY2022 | Q3 | - | $18M | $0.44 |
| FY2022 | FY | $942M | $49M | $1.21 |
| FY2023 | Q1 | $233M | $4M | $0.10 |
| FY2023 | Q2 | $245M | $7M | $0.18 |
| FY2023 | Q3 | $246M | $10M | $0.25 |
| FY2023 | FY | $978M | $33M | $0.81 |
| FY2024 | Q1 | $231M | $-8M | $-0.20 |
| FY2024 | Q2 | $250M | $1M | $0.03 |
| FY2024 | Q3 | $263M | $8M | $0.21 |
| FY2024 | FY | $1.0B | $2M | $0.06 |
| FY2025 | Q1 | $260M | $7M | $0.17 |
| FY2025 | Q2 | $309M | $3M | $0.08 |
| FY2025 | Q3 | $348M | $21M | $0.51 |
| FY2025 | FY | $1.3B | $48M | $1.19 |
| FY2026 | Q1 | $364M | $27M | $0.65 |
| FY2026 | Q2 | $374M | $27M | $0.67 |
| FY2026 | Q3 | $384M | $24M | $0.59 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | $942M | $978M | $1.0B | $1.3B |
| 営業利益 | $86M | $98M | $99M | $83M | $69M | $75M | $79M | $72M | $53M | $110M |
| 純利益 | $83M | $65M | $65M | $55M | $34M | $54M | $49M | $33M | $2M | $48M |
| 総資産 | $610M | $623M | $672M | $727M | $784M | $841M | $932M | $971M | $982M | $1.4B |
| 純資産 | - | - | - | - | - | - | - | $283M | $257M | $286M |
| 自己資本 | $90M | $151M | $185M | $216M | $188M | $239M | $262M | $283M | $257M | $286M |
| 営業CF | - | - | $70M | $47M | $59M | $48M | $32M | $13M | $88M | $80M |
| EPS | $2.07 | $1.61 | $1.61 | $1.35 | $0.83 | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 |
| BPS | - | - | - | - | - | - | - | - | - | - |
| ROE | 91.4% | 42.7% | 35.1% | 25.3% | 17.8% | 22.8% | 18.7% | 11.5% | 0.9% | 16.9% |